Raising the Voice: A Comment on Race and Ethnic Disparities in Alzheimer’s Disease Clinical Research

Alzheimer's Disease clinical research has faced a significant challenge for a long time in achieving diverse racial or ethnic representation in clinical trials. Many of these issues are rooted in deeper structural problems that leave some populations apart from the scope of science. While much work remains to be done to address this subject, there is a growing demand for more representative clinical trial data.

Hypertension, or high blood pressure, significantly impacts public health worldwide. Hypertension is well recognized for its role in cardiovascular disease, revealing implications for cognitive decline and dementia. Increasing clinical evidence for the early detection, management, and prevention of this condition may provide insights into a more comprehensive patient care, a more effective prevention of cognitive decline, and an improvement of overall quality of life.

Both the primary and secondary objectives aim to evaluate the efficacy of IGC-AD1 in reducing agitation as assessed by the CMAI at week 2 and week 6 respectively.

Parkinson's awareness month ____________________________ Parkinson’s disease psychosis is a neuropsychiatric complication that affects more than 20% of patients affected by Parkinson’s. Common symptoms involve visual or auditory hallucinations, distorted perception, and experiences. More challenging symptoms may occur in the form of delusions, which often cause agitation, aggressiveness, and affect the quality of life of the patient and their families.

By: Faith Ashmore Benzinga …

By:   Faith Ashmore …